BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
Metrics to compare | 4694 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4694PeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.3x | 15.3x | −0.6x | |
PEG Ratio | 1.26 | 0.45 | 0.00 | |
Price/Book | 1.1x | 1.2x | 2.6x | |
Price / LTM Sales | 1.0x | 0.5x | 3.3x | |
Upside (Analyst Target) | 9.7% | −2.9% | 38.7% | |
Fair Value Upside | Unlock | 29.3% | 3.2% | Unlock |